UniProt ID | ABL1_MOUSE | |
---|---|---|
UniProt AC | P00520 | |
Protein Name | Tyrosine-protein kinase ABL1 | |
Gene Name | Abl1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1123 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. The myristoylated c-ABL protein is reported to be nuclear. Sequestered into the cytoplasm through interaction with 14-3-3 proteins (By similarity). Localizes to mitochondria in response to oxidative st | |
Protein Description | Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (By similarity). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-191' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. Regulates T-cell differentiation in a TBX21-dependent manner. [PubMed: 21690296 Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity] | |
Protein Sequence | MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGTRGGAGSMLQAPELPTKTRTCRRAAEQKDAPDTPELLHTKGLGESDALDSEPAVSPLLPRKERGPPDGSLNEDERLLPRDRKTNLFSALIKKKKKMAPTPPKRSSSFREMDGQPDRRGASEDDSRELCNGPPALTSDAAEPTKSPKASNGAGVPNGAFREPGNSGFRSPHMWKKSSTLTGSRLAAAEEESGMSSSKRFLRSCSASCMPHGARDTEWRSVTLPRDLPSAGKQFDSSTFGGHKSEKPALPRKRTSESRSEQVAKSTAMPPPRLVKKNEEAAEEGFKDTESSPGSSPPSLTPKLLRRQVTASPSSGLSHKEEATKGSASGMGTPATAEPAPPSNKVGLSKASSEEMRVRRHKHSSESPGRDKGRLAKLKPAPPPPPACTGKAGKPAQSPSQEAGEAGGPTKTKCTSLAMDAVNTDPTKAGPPGEGLRKPVPPSVPKPQSTAKPPGTPTSPVSTPSTAPAPSPLAGDQQPSSAAFIPLISTRVSLRKTRQPPERIASGTITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLESNLRELQICPATASSGPAATQDFSKLLSSVKEISDIVRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 4) | Myristoylation | - | 10.12 | 12654251 | |
16 (in isoform 4) | Phosphorylation | - | 34.23 | 26824392 | |
43 | Phosphorylation | DFEPQGLSEAARWNS CCCCCCHHHHHHHCC | 31.82 | 26643407 | |
50 | Phosphorylation | SEAARWNSKENLLAG HHHHHHCCCCCCCCC | 34.09 | 26824392 | |
70 | Phosphorylation | PNLFVALYDFVASGD CCCEEEEEEHHHCCC | 9.52 | - | |
93 | Phosphorylation | EKLRVLGYNHNGEWC CEEEEEEECCCCCEE | 14.75 | 47733 | |
115 | Phosphorylation | QGWVPSNYITPVNSL CCCCCCCCCCCCHHH | 15.54 | 23069 | |
128 | Phosphorylation | SLEKHSWYHGPVSRN HHCCCCCCCCCCCCH | 10.42 | 61675 | |
139 | Phosphorylation | VSRNAAEYLLSSGIN CCCHHHHHHHHCCCC | 14.28 | 48383 | |
172 | Phosphorylation | LRYEGRVYHYRINTA EEECCEEEEEEEEEC | 7.56 | 65559 | |
174 | Phosphorylation | YEGRVYHYRINTASD ECCEEEEEEEEECCC | 8.76 | 65711 | |
178 | Phosphorylation | VYHYRINTASDGKLY EEEEEEEECCCCCEE | 25.76 | 24453211 | |
180 | Phosphorylation | HYRINTASDGKLYVS EEEEEECCCCCEEEC | 44.87 | 29514104 | |
185 | Phosphorylation | TASDGKLYVSSESRF ECCCCCEEECCHHHH | 11.19 | 12522270 | |
187 | O-linked_Glycosylation | SDGKLYVSSESRFNT CCCCEEECCHHHHHH | 18.16 | 30059200 | |
215 | Phosphorylation | GLITTLHYPAPKRNK CCEEECCCCCCCCCC | 12.28 | - | |
226 | Phosphorylation | KRNKPTIYGVSPNYD CCCCCCEEEECCCCC | 17.60 | 12522270 | |
229 | Phosphorylation | KPTIYGVSPNYDKWE CCCEEEECCCCCCCC | 11.76 | - | |
232 | Phosphorylation | IYGVSPNYDKWEMER EEEECCCCCCCCEEC | 23.45 | 23075 | |
253 | Phosphorylation | HKLGGGQYGEVYEGV ECCCCCCCCEEECCH | 20.66 | 23077 | |
257 | Phosphorylation | GGQYGEVYEGVWKKY CCCCCEEECCHHHHE | 11.58 | 23023260 | |
264 | Phosphorylation | YEGVWKKYSLTVAVK ECCHHHHEEEEEEEE | 12.75 | 12522270 | |
389 | Phosphorylation | FGLSRLMTGDTYTAH HCCCHHCCCCCEECC | 36.18 | 22499769 | |
392 | Phosphorylation | SRLMTGDTYTAHAGA CHHCCCCCEECCCCC | 24.90 | 22499769 | |
393 | Phosphorylation | RLMTGDTYTAHAGAK HHCCCCCEECCCCCC | 13.48 | 25521595 | |
394 | Phosphorylation | LMTGDTYTAHAGAKF HCCCCCEECCCCCCC | 17.66 | 12522270 | |
413 | Phosphorylation | TAPESLAYNKFSIKS CCCHHHHCCCCCCCC | 24.95 | 47737 | |
446 | Phosphorylation | PYPGIDLSQVYELLE CCCCCCHHHHHHHHH | 17.53 | 9109492 | |
469 | Phosphorylation | EGCPEKVYELMRACW CCCCHHHHHHHHHHH | 17.89 | 12522270 | |
547 | Phosphorylation | EQKDAPDTPELLHTK HHCCCCCCHHHHCCC | 20.01 | 1956339 | |
553 | Phosphorylation | DTPELLHTKGLGESD CCHHHHCCCCCCCCC | 27.12 | 28066266 | |
559 | Phosphorylation | HTKGLGESDALDSEP CCCCCCCCCCCCCCC | 26.78 | - | |
564 | Phosphorylation | GESDALDSEPAVSPL CCCCCCCCCCCCCCC | 46.45 | 23984901 | |
569 | Phosphorylation | LDSEPAVSPLLPRKE CCCCCCCCCCCCCHH | 16.37 | 27087446 | |
618 | Phosphorylation | APTPPKRSSSFREMD CCCCCCCCCCHHHCC | 36.14 | 30635358 | |
619 | Phosphorylation | PTPPKRSSSFREMDG CCCCCCCCCHHHCCC | 37.21 | 29899451 | |
620 | Phosphorylation | TPPKRSSSFREMDGQ CCCCCCCCHHHCCCC | 29.57 | 8548467 | |
656 | Phosphorylation | TSDAAEPTKSPKASN CCCCCCCCCCCCCCC | 35.34 | 30482847 | |
658 | Phosphorylation | DAAEPTKSPKASNGA CCCCCCCCCCCCCCC | 33.83 | 27149854 | |
682 | Phosphorylation | PGNSGFRSPHMWKKS CCCCCCCCCCCCCCC | 19.52 | - | |
689 | Phosphorylation | SPHMWKKSSTLTGSR CCCCCCCCCCCCHHH | 25.48 | 29514104 | |
690 | Phosphorylation | PHMWKKSSTLTGSRL CCCCCCCCCCCHHHH | 35.99 | 27600695 | |
693 | Phosphorylation | WKKSSTLTGSRLAAA CCCCCCCCHHHHHHH | 32.95 | 28576409 | |
710 | Acetylation | ESGMSSSKRFLRSCS HHCCCHHHHHHHHCC | 49.47 | - | |
715 | Phosphorylation | SSKRFLRSCSASCMP HHHHHHHHCCCCCCC | 17.99 | 25521595 | |
717 | Phosphorylation | KRFLRSCSASCMPHG HHHHHHCCCCCCCCC | 25.18 | 25266776 | |
719 | Phosphorylation | FLRSCSASCMPHGAR HHHHCCCCCCCCCCC | 8.48 | 26643407 | |
734 | Phosphorylation | DTEWRSVTLPRDLPS CCCCEEEECCCCCCC | 32.09 | 27149854 | |
750 | Phosphorylation | GKQFDSSTFGGHKSE CCCCCCCCCCCCCCC | 30.19 | 29514104 | |
769 | Phosphorylation | PRKRTSESRSEQVAK CCCCCCCCHHHHHHH | 40.65 | - | |
800 | Phosphorylation | AEEGFKDTESSPGSS HHHCCCCCCCCCCCC | 38.05 | 25619855 | |
802 | Phosphorylation | EGFKDTESSPGSSPP HCCCCCCCCCCCCCC | 43.88 | 25619855 | |
803 | Phosphorylation | GFKDTESSPGSSPPS CCCCCCCCCCCCCCC | 27.35 | 25619855 | |
806 | Phosphorylation | DTESSPGSSPPSLTP CCCCCCCCCCCCCCH | 42.95 | 25619855 | |
807 | Phosphorylation | TESSPGSSPPSLTPK CCCCCCCCCCCCCHH | 46.90 | 25521595 | |
810 | Phosphorylation | SPGSSPPSLTPKLLR CCCCCCCCCCHHHHH | 48.54 | 25619855 | |
812 | Phosphorylation | GSSPPSLTPKLLRRQ CCCCCCCCHHHHHHH | 23.79 | 25619855 | |
821 | Phosphorylation | KLLRRQVTASPSSGL HHHHHHCCCCCCCCC | 17.06 | 29514104 | |
823 | Phosphorylation | LRRQVTASPSSGLSH HHHHCCCCCCCCCCC | 18.89 | 29472430 | |
825 | Phosphorylation | RQVTASPSSGLSHKE HHCCCCCCCCCCCHH | 34.25 | 29472430 | |
844 | Phosphorylation | GSASGMGTPATAEPA CCCCCCCCCCCCCCC | 10.80 | - | |
902 | Acetylation | PPPACTGKAGKPAQS CCCCCCCCCCCCCCC | 35.49 | 21781306 | |
909 | Phosphorylation | KAGKPAQSPSQEAGE CCCCCCCCCCCCCHH | 28.73 | 25521595 | |
911 | Phosphorylation | GKPAQSPSQEAGEAG CCCCCCCCCCCHHCC | 45.99 | 30635358 | |
970 | Phosphorylation | KPPGTPTSPVSTPST CCCCCCCCCCCCCCC | 25.22 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
226 | Y | Phosphorylation | Kinase | ABL1 | P00520 | GPS |
393 | Y | Phosphorylation | Kinase | ABL1 | P00520 | PhosphoELM |
393 | Y | Phosphorylation | Kinase | HCK | P08631 | PSP |
393 | Y | Phosphorylation | Kinase | HCK | P08103 | PSP |
393 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
393 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
547 | T | Phosphorylation | Kinase | CDK1 | P11440 | PSP |
547 | T | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
547 | T | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
569 | S | Phosphorylation | Kinase | CDK1 | P11440 | PSP |
569 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
569 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
618 | S | Phosphorylation | Kinase | PAK2 | Q8CIN4 | Uniprot |
619 | S | Phosphorylation | Kinase | PAK2 | Q8CIN4 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ABL1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RIN1_MOUSE | Rin1 | physical | 9144171 | |
PAXI_MOUSE | Pxn | physical | 9603926 | |
ABL1_MOUSE | Abl1 | physical | 11274764 | |
PTN11_MOUSE | Ptpn11 | physical | 9393882 | |
CBL_MOUSE | Cbl | physical | 9393882 | |
CRKL_MOUSE | Crkl | physical | 8978305 | |
CBL_MOUSE | Cbl | physical | 10391678 | |
CBL_MOUSE | Cbl | physical | 8635998 | |
SHIP1_MOUSE | Inpp5d | physical | 11031258 | |
DOK1_MOUSE | Dok1 | physical | 10823839 | |
PPARG_MOUSE | Pparg | physical | 25368164 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Functional interaction between DNA-PK and c-Abl in response to DNAdamage."; Kharbanda S., Pandey P., Jin S., Inoue S., Bharti A., Yuan Z.-M.,Weichselbaum R., Weaver D., Kufe D.; Nature 386:732-735(1997). Cited for: FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, PHOSPHORYLATION ATSER-446, AND MUTAGENESIS OF SER-446. | |
"Differential phosphorylation of c-Abl in cell cycle determined bycdc2 kinase and phosphatase activity."; Kipreos E.T., Wang J.Y.; Science 248:217-220(1990). Cited for: PHOSPHORYLATION AT THR-547 AND SER-569. | |
"Structural mechanism for STI-571 inhibition of Abelson tyrosinekinase."; Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B.,Kuriyan J.; Science 289:1938-1942(2000). Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 229-515 IN COMPLEX WITHINHIBITOR STI-571, CATALYTIC ACTIVITY, ENZYME REGULATION,PHOSPHORYLATION AT TYR-393, AND ACTIVATION LOOP. | |
"Two distinct phosphorylation pathways have additive effects on Ablfamily kinase activation."; Tanis K.Q., Veach D., Duewel H.S., Bornmann W.G., Koleske A.J.; Mol. Cell. Biol. 23:3884-3896(2003). Cited for: FUNCTION, ENZYME REGULATION, INTERACTION WITH CRK, AUTOPHOSPHORYLATIONAT TYR-226 AND TYR-393, AND MUTAGENESIS OF TYR-226; LYS-271 ANDTYR-393. |